Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and …
MD Tacca - Current Cancer Drug Targets, 2010 - ingentaconnect.com
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
[PDF][PDF] Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in …
F Loupakis, G Bocci, G Pasqualetti… - Current Cancer Drug …, 2010 - researchgate.net
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and …
F Loupakis, G Bocci, G Pasqualetti… - … cancer drug targets, 2010 - pubmed.ncbi.nlm.nih.gov
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and …
F Loupakis, G Bocci, G Pasqualetti… - Current Cancer Drug …, 2010 - europepmc.org
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
Targeting vascular endothelial growth factor pathway in first-line treatment of metastatic colorectal cancer: state-of-the-art and future perspectives in clinical and …
F Loupakis, G Bocci, G Pasqualetti, L Fornaro… - CURRENT CANCER …, 2010 - arpi.unipi.it
argeting vascular endothelial growth factor (VEGF) pathway represents a successful strategy
in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the first …
in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the first …
[PDF][PDF] Targeting Vascular Endothelial Growth Factor Pathway in First-Line Treatment of Metastatic Colorectal Cancer: State-of-the-Art and Future Perspectives in …
F Loupakis, G Bocci, G Pasqualetti… - Current Cancer Drug …, 2010 - researchgate.net
Targeting vascular endothelial growth factor (VEGF) pathway represents a successful
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …
strategy in the treatment of metastatic colorectal cancer (mCRC). Since the approval of the …